STAP Misconduct Investigator Steps Down

One of the RIKEN scientists investigating allegations of misconduct tied to stimulus-triggered acquisition of pluripotency work has resigned from the committee because of anonymous questions raised about his own research.

Written byTracy Vence
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

FLICKR, JOHN LESTERA RIKEN scientist investigating allegations of misconduct tied to Haruko Obokata and her colleagues’ stimulus-triggered acquisition of pluripotency (STAP) work has resigned from his post on the committee amidst alleged problems with his own published research, the Nature News blog reported. In a statement, molecular biologist Shunsuke Ishii from the RIKEN Advanced Science Institute said he chose to step down from the STAP misconduct investigation committee because of anonymous comments expressing doubt about data in two of his lab’s papers. In his statement, Ishii “deeply apologize[d]” for the inconvenience caused.

Earlier this month (April 1), the RIKEN committee reported evidence of data falsification and fabrication in the STAP papers. While a separate committee is working to determine whether the publications should be retracted and how Obokata might be disciplined for her alleged misconduct, the stem-cell researcher has stood by her results. “At this stage, considering the STAP cell discovery itself to be fabricated is a misunderstanding; I cannot possibly accept this,” Obokata said in an April 1 statement.

Now, Nature reported, Obokata’s lawyer said that questions about the validity of Ishii’s work are reason for a reinvestigation of the initial RIKEN report on STAP. Meanwhile, RIKEN will investigate claims related to Ishii’s research.

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies